“Long-term Safety and Efficacy of SBRT with Volumetric Modulated Arc Therapy and Flattening Filter Free Beams for Low-Intermediate Risk Prostate Cancer”

https://pubmed.ncbi.nlm.nih.gov/38112222

The long-term update of a phase II trial shows that stereotactic body radiation therapy (SBRT) delivered with Volumetric Modulated Arc Therapy and Flattening Filter Free beams is a safe and effective treatment option for low-intermediate risk prostate cancer, with low toxicity and good long-term survival rates.